Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models
- 16 May 1983
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 112 (3), 899-906
- https://doi.org/10.1016/0006-291x(83)91702-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- PLASMA THROMBOXANE CONCENTRATIONS ARE RAISED IN PATIENTS DYING WITH SEPTIC SHOCKThe Lancet, 1982
- Thromboxanes and prostacyclin: Positive and negative modulators of tumor growthBiochemical and Biophysical Research Communications, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function.JCI Insight, 1980
- Elevated Thromboxane Levels in the Rat during Endotoxic ShockJCI Insight, 1980
- On the inhibitory potency of imidazole and its derivatives on thromboxane synthetaseBiochemical and Biophysical Research Communications, 1978
- Arachidonate lipoxygenase in blood plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975
- Radioimmunoassay Measurement of Prostaglandins E, A, and F in Human PlasmaJCI Insight, 1973
- Mechanism of prostaglandin biosynthesis. I. Characterization and assay of bovine prostaglandin synthetaseBiochemistry, 1971
- A SIMPLE AND EFFICIENT METHOD OF SEPARATING PERIPHERAL-BLOOD LEUCOCYTES FOR IN-VITRO STUDIESThe Lancet, 1967